{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:07:51Z","timestamp":1792825671149,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-99206-2","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T05:54:39Z","timestamp":1745906079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cross-tissue MiRNA profiling of extracellular vesicles and PBMCs from amyotrophic lateral sclerosis patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Francesca","family":"Dragoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinda Di","family":"Gerlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Diamanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartolo","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bordoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveljn","family":"Scarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Viola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Cerchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Zucca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orietta","family":"Pansarasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Gagliardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"99206_CR1","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman, O. et al. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Prim. 3, 17071. https:\/\/doi.org\/10.1038\/nrdp.2017.71 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"99206_CR2","doi-asserted-by":"publisher","unstructured":"D\u2019Erchia, A. M. et al. Massive transcriptome sequencing of human spinal cord tissues provides new insights into motor neuron degeneration in ALS. Sci. Rep. 7. https:\/\/doi.org\/10.1038\/s41598-017-10488-7 (2017).","DOI":"10.1038\/s41598-017-10488-7"},{"key":"99206_CR3","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/jamaneurol.2017.0357","volume":"74","author":"W Zhao","year":"2017","unstructured":"Zhao, W. et al. Characterization of gene expression phenotype in amyotrophic lateral sclerosis monocytes. JAMA Neurol. 74, 677\u2013685. https:\/\/doi.org\/10.1001\/jamaneurol.2017.0357 (2017).","journal-title":"JAMA Neurol."},{"key":"99206_CR4","doi-asserted-by":"publisher","unstructured":"Gagliardi, S. et al. Long non-coding and coding RNAs characterization in peripheral blood mononuclear cells and spinal cord from amyotrophic lateral sclerosis patients. Sci. Rep. 8. https:\/\/doi.org\/10.1038\/s41598-018-20679-5 (2018).","DOI":"10.1038\/s41598-018-20679-5"},{"key":"99206_CR5","doi-asserted-by":"publisher","first-page":"190006","DOI":"10.1038\/sdata.2019.6","volume":"6","author":"S Zucca","year":"2019","unstructured":"Zucca, S. et al. RNA-Seq profiling in peripheral blood mononuclear cells of amyotrophic lateral sclerosis patients and controls. Sci. Data. 6, 190006. https:\/\/doi.org\/10.1038\/sdata.2019.6 (2019).","journal-title":"Sci. Data"},{"key":"99206_CR6","doi-asserted-by":"publisher","unstructured":"Garofalo, M. et al. RNA molecular signature profiling in PBMCs of sporadic ALS patients: HSP70 overexpression is associated with nuclear SOD1. Cells 11 https:\/\/doi.org\/10.3390\/cells11020293 (2022).","DOI":"10.3390\/cells11020293"},{"issue":"12","key":"99206_CR7","doi-asserted-by":"publisher","first-page":"7104","DOI":"10.1007\/s12035-023-03520-7","volume":"60","author":"BC Gomes","year":"2023","unstructured":"Gomes, B. C. et al. Differential expression of MiRNAs in amyotrophic lateral sclerosis patients. Mol. Neurobiol. 60 (12), 7104\u20137117. https:\/\/doi.org\/10.1007\/s12035-023-03520-7 (2023).","journal-title":"Mol. Neurobiol."},{"key":"99206_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2018.1535750","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry, C. et al. A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles. 7, 1535750. https:\/\/doi.org\/10.1080\/20013078.2018.1535750 (2018). Minimal information for studies of extracellular vesicles 2018 (MISEV2018."},{"key":"99206_CR9","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tcb.2015.01.004","volume":"25","author":"E Cocucci","year":"2015","unstructured":"Cocucci, E. & Meldolesi, J. Ectosomes and exossomes: shedding the confusion between extracellular vesicles. Trends Cell. Biol. 25, 364\u2013372. https:\/\/doi.org\/10.1016\/j.tcb.2015.01.004 (2015).","journal-title":"Trends Cell. Biol."},{"key":"99206_CR10","doi-asserted-by":"publisher","unstructured":"Sproviero, D. et al. Different MiRNA profiles in plasma derived small and large extracellular vesicles from patients with neurodegenerative diseases. Int. J. Mol. Sci. (2021) Mar. 8, 22(5):2737. https:\/\/doi.org\/10.3390\/ijms22052737","DOI":"10.3390\/ijms22052737"},{"key":"99206_CR11","doi-asserted-by":"publisher","unstructured":"Sproviero, D. et al. Extracellular vesicles derived from plasma of patients with neurodegenerative disease have common transcriptomic profiling. Front. Aging Neurosci. (2022) Feb 16, 14:785741. https:\/\/doi.org\/10.3389\/fnagi.2022.785741","DOI":"10.3389\/fnagi.2022.785741"},{"key":"99206_CR12","doi-asserted-by":"publisher","unstructured":"Kim, J. A. et al. Small RNA sequencing of Circulating small extracellular vesicles MicroRNAs in patients with amyotrophic lateral sclerosis. Sci. Rep. (2023) Apr 4, 13(1):5528. https:\/\/doi.org\/10.1038\/s41598-023-32717-y","DOI":"10.1038\/s41598-023-32717-y"},{"issue":"2","key":"99206_CR13","doi-asserted-by":"publisher","first-page":"e31630","DOI":"10.1371\/journal.pone.0031630","volume":"7","author":"F Cordero","year":"2012","unstructured":"Cordero, F. et al. Optimizing a massive parallel sequencing workflow for quantitative MiRNA expression analysis. PLoS One. 7 (2), e31630. https:\/\/doi.org\/10.1371\/journal.pone.0031630 (2012).","journal-title":"PLoS One"},{"issue":"Suppl 10","key":"99206_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12859-018-2296-x","volume":"Oct 15","author":"N Kulkarni","year":"2018","unstructured":"Kulkarni, N. et al. Reproducible bioinformatics project: a community for reproducible bioinformatics analysis pipelines. BMC Bioinform. Oct 15 (Suppl 10), 349. https:\/\/doi.org\/10.1186\/s12859-018-2296-x (2018).","journal-title":"BMC Bioinform."},{"key":"99206_CR15","doi-asserted-by":"publisher","unstructured":"Mazin, A. V. et al. Rad54, the motor of homologous recombination, DNA repair (Amst). Mar 2, 9(3):286\u2013302. (2010). https:\/\/doi.org\/10.1016\/j.dnarep.2009.12.006","DOI":"10.1016\/j.dnarep.2009.12.006"},{"key":"99206_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/nar\/gkw377","volume":"44 (1)","author":"MVS Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. S. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44 (1), 90\u201397. https:\/\/doi.org\/10.1093\/nar\/gkw377 (2016).","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"99206_CR17","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1073\/pnas.1218497110","volume":"Mar 5","author":"F Bi","year":"2013","unstructured":"Bi, F. et al. Reactive astrocytes secrete lcn2 to promote neuron death. Proc. Natl. Acad. Sci. U S A. Mar 5 (10), 4069\u20134074. https:\/\/doi.org\/10.1073\/pnas.1218497110 (2013).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"99206_CR18","doi-asserted-by":"publisher","unstructured":"Sticht, C. et al. MiRWalk: an online resource for prediction of MicroRNA binding sites. PLoS One. Oct 18 (10). https:\/\/doi.org\/10.1371\/journal.pone.0206239 (2018).","DOI":"10.1371\/journal.pone.0206239"},{"issue":"2","key":"99206_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/mus.26106","volume":"58","author":"R Raheja","year":"2018","unstructured":"Raheja, R. et al. Correlating serum Micrornas and clinical parameters in amyotrophic lateral sclerosis. Muscle Nerve. 58 (2), 261\u2013269. https:\/\/doi.org\/10.1002\/mus.26106 (2018).","journal-title":"Muscle Nerve"},{"issue":"13","key":"99206_CR20","doi-asserted-by":"publisher","first-page":"J1","DOI":"10.3390\/cells12131763","volume":"12","author":"GJM Afonso","year":"2023","unstructured":"Afonso, G. J. M., Cavaleiro, C., Valero, J. & Mota, S. I. Ferreiro. Recent advances in extracellular vesicles in amyotrophic lateral sclerosis and emergent perspectives. Cells 12 (13), J1. https:\/\/doi.org\/10.3390\/cells12131763 (2023).","journal-title":"Cells"},{"issue":"1","key":"99206_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12974-018-1135-3","volume":"Mar 28","author":"C Perner","year":"2018","unstructured":"Perner, C. et al. Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients. J. Neuroinflammation. Mar 28 (1), 99. https:\/\/doi.org\/10.1186\/s12974-018-1135-3 (2018).","journal-title":"J. Neuroinflammation"},{"key":"99206_CR22","doi-asserted-by":"publisher","unstructured":"Wong, K. M. et al. Mutations in TAF8 cause a neurodegenerative disorder. Brain (2022) Sep. 14, 145(9):3022\u20133034. https:\/\/doi.org\/10.1093\/brain\/awac154","DOI":"10.1093\/brain\/awac154"},{"key":"99206_CR23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jns.2017.07.008","volume":"380","author":"V Pegoraro","year":"2017","unstructured":"Pegoraro, V., Merico, A. & Angelini, C. Micro-RNAs in ALS muscle: differences in gender, age at onset and disease duration. J. Neurol. Sci. 380, 58\u201363. https:\/\/doi.org\/10.1016\/j.jns.2017.07.008 (2017). Sep 15.","journal-title":"J. Neurol. Sci."},{"key":"99206_CR24","doi-asserted-by":"publisher","unstructured":"Freischmidt, A. et al. Systemic dysregulation of TDP-43 binding MicroRNAs in amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 1 (42). https:\/\/doi.org\/10.1186\/2051-5960-1-42 (2013). Jul 30.","DOI":"10.1186\/2051-5960-1-42"},{"issue":"3","key":"99206_CR25","doi-asserted-by":"publisher","first-page":"345","DOI":"10.7150\/ijbs.10921","volume":"Feb 5","author":"G Ma","year":"2015","unstructured":"Ma, G. et al. MiR-206, a key modulator of skeletal muscle development and disease. Int. J. Biol. Sci. Feb 5 (3), 345\u2013352. https:\/\/doi.org\/10.7150\/ijbs.10921 (2015).","journal-title":"Int. J. Biol. Sci."},{"key":"99206_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2010.235952","author":"A Chi\u00f2","year":"2011","unstructured":"Chi\u00f2, A. et al. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J. Neurol. Neurosurg. Psychiatry. https:\/\/doi.org\/10.1136\/jnnp.2010.235952 (2011).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"99206_CR27","doi-asserted-by":"publisher","first-page":"106823","DOI":"10.1016\/j.nbd.2025.106823","volume":"206","author":"F Dragoni","year":"2025","unstructured":"Dragoni, F. et al. Whole transcriptome analysis of unmutated sporadic ALS patients\u2019 peripheral blood reveals phenotype-specific gene expression signature. Neurobiol. Dis. 206, 106823. https:\/\/doi.org\/10.1016\/j.nbd.2025.106823 (2025).","journal-title":"Neurobiol. Dis."},{"issue":"12","key":"99206_CR28","doi-asserted-by":"publisher","first-page":"e1009951","DOI":"10.1371\/journal.pgen.1009951","volume":"17","author":"M Albanese","year":"2021","unstructured":"Albanese, M. et al. Hammerschmidt. MicroRNAs are minor constituents of extracellular vesicles that are rarely delivered to target cells. PLoS Genet. 17 (12), e1009951. https:\/\/doi.org\/10.1371\/journal.pgen.1009951 (2021).","journal-title":"PLoS Genet."},{"key":"99206_CR29","doi-asserted-by":"publisher","unstructured":"Ayka, A. & \u015eehirli, A. \u00d6. The role of the SLC transporters protein in the neurodegenerative disorders. Clin. Psychopharmacol. Neurosci. (2020) May 31, 18(2):174\u2013187. https:\/\/doi.org\/10.9758\/cpn.2020.18.2.174","DOI":"10.9758\/cpn.2020.18.2.174"},{"key":"99206_CR30","doi-asserted-by":"publisher","unstructured":"Xue, Y. C. et al. Dysregulation of RNA-Binding proteins in amyotrophic lateral sclerosis. Front. Mol. Neurosci. (2020) May 29, 13:78. https:\/\/doi.org\/10.3389\/fnmol.2020.00078","DOI":"10.3389\/fnmol.2020.00078"},{"key":"99206_CR31","doi-asserted-by":"publisher","unstructured":"Conlon, E. G., Manley, J. L. & Genes Dev. RNA-binding proteins in neurodegeneration: mechanisms in aggregate,. Aug 1, 31(15):1509\u20131528. (2017). https:\/\/doi.org\/10.1101\/gad.304055.117. Erratum in: Genes Dev. 2017;31(19):2015.","DOI":"10.1101\/gad.304055.117"},{"key":"#cr-split#-99206_CR32.1","unstructured":"Ball, M. et al. Oct 30 [updated 2024 May 9]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle"},{"key":"#cr-split#-99206_CR32.2","unstructured":"1993-2024. (2003). Available from http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1173"},{"key":"99206_CR33","doi-asserted-by":"publisher","unstructured":"Podmanicky, O. et al. Mitochondrial aminoacyl-tRNA synthetases trigger unique compensatory mechanisms in neurons. Hum. Mol. Genet. 435\u2013447. https:\/\/doi.org\/10.1093\/hmg\/ddad196 (2024).","DOI":"10.1093\/hmg\/ddad196"},{"key":"99206_CR34","doi-asserted-by":"publisher","unstructured":"Nataf, S. & Pays, L. Gene co-expression analysis unravels a link between C9orf72 and RNA metabolism in myeloid cells. Acta Neuropathol. Commun. (2015) Oct. 15, 3:64. https:\/\/doi.org\/10.1186\/s40478-015-0242-y","DOI":"10.1186\/s40478-015-0242-y"},{"key":"99206_CR35","doi-asserted-by":"publisher","unstructured":"Baker, D. J. et al. Lysosomal and phagocytic activity is increased in astrocytes during disease progression in the SOD1 (G93A) mouse model of amyotrophic lateral sclerosis. Front. Cell. Neurosci. (2015) Oct. 15;9:410. https:\/\/doi.org\/10.3389\/fncel.2015.00410","DOI":"10.3389\/fncel.2015.00410"},{"key":"99206_CR36","doi-asserted-by":"crossref","unstructured":"Marcello, E., Borroni, B., Pelucchi, S., Gardoni, F. & Di Luca, M. ADAM10 as a therapeutic target for brain diseases: from developmental disorders to Alzheimer\u2019s disease. Expert Opin Ther Targets. ;21(11):1017\u20131026. doi: 10.1080\/14728222.2017.1386176. Epub 2017 Oct 3. PMID: 28960088. (2017).","DOI":"10.1080\/14728222.2017.1386176"},{"key":"99206_CR37","doi-asserted-by":"publisher","unstructured":"Davies, S. P. et al. 5\u2019-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2\u00a0C alpha and native bovine protein phosphatase-2AC. FEBS Lett. (199) 377:421\u2013425. https:\/\/doi.org\/10.1016\/0014-5793(95)01368-7","DOI":"10.1016\/0014-5793(95)01368-7"},{"key":"99206_CR38","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.neurobiolaging.2014.09.022","volume":"36","author":"KS Coughlan","year":"2015","unstructured":"Coughlan, K. S. et al. Preconditioning with latrepirdine, an adenosine 5\u2019-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1(G93A) mice. Neurobiol. Aging. 36, 1140\u20131150. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.09.022 (2015).","journal-title":"Neurobiol. Aging"},{"key":"99206_CR39","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3389\/fneur.2019.00578","volume":"11","author":"S Foggin","year":"2019","unstructured":"Foggin, S. et al. Biological significance of MicroRNA biomarkers in ALS-Innocent bystanders or disease culprits?? Front neurol. Jun 11, 10:578. https:\/\/doi.org\/10.3389\/fneur.2019.00578 (2019).","journal-title":"Jun"},{"key":"99206_CR40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12974-018-1255-9","volume":"15","author":"A Sogorb-Esteve","year":"2018","unstructured":"Sogorb-Esteve, A. et al. Levels of ADAM10 are reduced in Alzheimer\u2019s disease CSF. J. Neuroinflammation. 15, 213. https:\/\/doi.org\/10.1186\/s12974-018-1255-9 (2018).","journal-title":"J. Neuroinflammation"},{"key":"99206_CR41","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00401-024-02763-5","volume":"148","author":"F Song","year":"2024","unstructured":"Song, F. et al. Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases. Acta Neuropathol. 148, 2. https:\/\/doi.org\/10.1007\/s00401-024-02763-5 (2024).","journal-title":"Acta Neuropathol."},{"key":"99206_CR42","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 14, 128. https:\/\/doi.org\/10.1186\/1471-2105-14-128 (2013).","journal-title":"BMC Bioinform."},{"key":"99206_CR43","doi-asserted-by":"publisher","unstructured":"Ferrari, R. et al. FTD and ALS: a Tale of two diseases. Curr. Alzheimer Res. (2011) May, 8(3):273\u2013294. https:\/\/doi.org\/10.2174\/156720511795563700","DOI":"10.2174\/156720511795563700"},{"key":"99206_CR44","doi-asserted-by":"publisher","unstructured":"Przanowska, R. K. et al. miR-206 family is important for mitochondrial and muscle function, but not essential for myogenesis in vitro. FASEB J. (2020) Jun, 34(6):7687\u20137702. https:\/\/doi.org\/10.1096\/fj.201902855RR","DOI":"10.1096\/fj.201902855RR"},{"key":"99206_CR45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ejphar.2017.10.012","volume":"15","author":"RM Liscic","year":"2017","unstructured":"Liscic, R. M. Als and Ftd: insights into the disease mechanisms and therapeutic targets. Eur. J. Pharmacol. 15, 817: 2\u20136. https:\/\/doi.org\/10.1016\/j.ejphar.2017.10.012 (2017).","journal-title":"Eur. J. Pharmacol."},{"key":"99206_CR46","doi-asserted-by":"publisher","unstructured":"Takahashi, Y. et al. ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19. Am. J. Hum. Genet. (2013) Nov 7, 93(5):900\u2013905. https:\/\/doi.org\/10.1016\/j.ajhg.2013.09.008","DOI":"10.1016\/j.ajhg.2013.09.008"},{"issue":"3","key":"99206_CR47","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1113\/JP270213","volume":"Feb 1","author":"D Arbour","year":"2017","unstructured":"Arbour, D., Vande Velde, C. & Robitaille, R. New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction. J. Physiol. Feb 1 (3), 647\u2013661. https:\/\/doi.org\/10.1113\/JP270213 (2017).","journal-title":"J. Physiol."},{"key":"99206_CR48","doi-asserted-by":"publisher","unstructured":"Tan, Y. et al. Downregulated miR-204 promotes skeletal muscle regeneration. Biomed. Res. Int. Nov 17, 2020 (3183296). https:\/\/doi.org\/10.1155\/2020\/3183296 (2020).","DOI":"10.1155\/2020\/3183296"},{"issue":"5","key":"99206_CR49","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3390\/cells10050991","volume":"10","author":"A Margiotta","year":"2021","unstructured":"Margiotta, A. Role of snares in neurodegenerative diseases. Cells 10 (5), 991. https:\/\/doi.org\/10.3390\/cells10050991 (2021). PMID: 33922505; PMCID: PMC8146804.","journal-title":"Cells"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99206-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99206-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99206-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T13:36:08Z","timestamp":1749648968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99206-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99206"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99206-2","relation":{"references":[{"id-type":"doi","id":"10.1080\/20013078.2018.1535750","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: In the original version of this Article, the author names were incorrectly indexed. The original Article has been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the Helsinki declaration and its later amendments or comparable ethical standards. The study design was examined by the IRBs of the enrolling institutions. The study protocol to obtain blood from patients and healthy controls was approved by the Ethical Committee of the IRCCS Mondino Foundation (Pavia, Italy) (Code: p-20180034329). Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"14976"}}